Fasedienol clinical trials
Also written PH94B.
How each study uses fasedienol is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
8 studies that test it; most in 2021 (4)
| Year | Studies |
|---|---|
| 2008 | 1 |
| 2014 | 1 |
| 2021 | 4 |
| 2024 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 8 · Other 0
VistaGen Therapeutics, Inc. (6) · Pherin Pharmaceuticals, Inc. (2)
Studies
Open first, then newest update. How each study uses fasedienol is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 8
- Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder (PALISADE-4)CompletedPhase 3VistaGen Therapeutics, Inc.NCT06615557Written as Fasedienol Nasal Spray
- Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder (PALISADE-3)CompletedPhase 3VistaGen Therapeutics, Inc.NCT06358651Written as Fasedienol Nasal Spray
- PH94B in the Treatment of Adjustment Disorder With AnxietyCompletedPhase 2VistaGen Therapeutics, Inc.NCT04404192Written as PH94B
- PH94B Nasal Spray for Anxiety Induced by a Public Speaking Challenge - 2TerminatedPhase 3VistaGen Therapeutics, Inc.NCT05011396Written as PH94B Nasal Spray
- Open-label Safety Trial of PH94B in Social Anxiety Disorder (SAD)TerminatedPhase 3VistaGen Therapeutics, Inc.NCT05030350Written as PH94B
- PH94B Nasal Spray for Anxiety Induced by a Public Speaking ChallengeCompletedPhase 3VistaGen Therapeutics, Inc.NCT04754802Written as PH94B Nasal Spray
- Feasibility Study of PH94B Nasal Spray for Acute Treatment of Social Anxiety Disorder (SAD)CompletedPhase 3Pherin Pharmaceuticals, Inc.NCT02622958Written as PH94B
- Intranasal PH94B for Management of the Symptoms of Generalized Social PhobiaCompletedPhase 2Pherin Pharmaceuticals, Inc.NCT01217788Written as PH94B intranasal spray
Codes
What other systems call fasedienol · ClinicalTrials.gg INT016369
- UNII (FDA) DTW1NJ7IJHFASEDIENOLOne source FDA
- NCI Thesaurus C188566FasedienolOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | DTW1NJ7IJH | FASEDIENOL | One source FDA |
| NCI Thesaurus | C188566 | Fasedienol | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.